These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 9862685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH, Gienapp IE, Cox KL, Whitacre CC.
    J Immunol; 1995 Aug 01; 155(3):1599-605. PubMed ID: 7543526
    [Abstract] [Full Text] [Related]

  • 5. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
    Matejuk A, Buenafe AC, Dwyer J, Ito A, Silverman M, Zamora A, Subramanian S, Vandenbark AA, Offner H.
    J Neurosci Res; 2003 Jan 01; 71(1):89-103. PubMed ID: 12478617
    [Abstract] [Full Text] [Related]

  • 6. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
    Abromson-Leeman S, Alexander J, Bronson R, Carroll J, Southwood S, Dorf M.
    J Immunol; 1995 Jan 01; 154(1):388-98. PubMed ID: 7527816
    [Abstract] [Full Text] [Related]

  • 7. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.
    Offner H, Adlard K, Bebo BF, Schuster J, Burrows GG, Buenafe AC, Vandenbark AA.
    J Immunol; 1998 Sep 01; 161(5):2178-86. PubMed ID: 9725209
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.
    Zhou SR, Whitaker JN, Han Q, Maier C, Blalock JE.
    J Immunol; 1994 Sep 01; 153(5):2340-51. PubMed ID: 7519648
    [Abstract] [Full Text] [Related]

  • 10. Differences between two strains of myelin basic protein (MBP) TCR transgenic mice: implications for tolerance induction.
    Song F, Wardrop RM, Gienapp IE, Stuckman SS, Goverman J, Whitacre CC.
    J Autoimmun; 2002 Feb 01; 18(1):27-37. PubMed ID: 11869044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
    Miller A, al-Sabbagh A, Santos LM, Das MP, Weiner HL.
    J Immunol; 1993 Dec 15; 151(12):7307-15. PubMed ID: 7505026
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.